Mucosal Healing in Inflammatory Bowel Disease: Where Do We Stand?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The definition of remission in Crohn’s disease and ulcerative colitis has evolved to include mucosal healing as a measure of treatment efficacy. Randomized, controlled trials have demonstrated mucosal healing is attainable with the current arsenal of therapies available to treat inflammatory bowel disease. Mucosal healing has been shown to reduce the likelihood of clinical relapse, reduce the risk of future surgeries, and reduce hospitalizations. This review focuses on the latest studies addressing clinical outcomes of mucosal healing in the clinical trial and practice setting.
- Mucosal Healing in Inflammatory Bowel Disease: Where Do We Stand?
Current Gastroenterology Reports
Volume 12, Issue 6 , pp 471-478
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Crohn’s disease
- Ulcerative colitis
- Mucosal healing
- Industry Sectors
- Author Affiliations
- 1. Division of Gastroenterology and Hepatology, The Johns Hopkins School of Medicine, 1830 East Monument Street, Room 434, Baltimore, MD, 21287, USA
- 2. The Henry J. Danowitz Division of Gastroenterology, The Mount Sinai School of Medicine, 1751 York Avenue, New York, NY, 10128, USA